Equities research analysts expect that Nu Skin Enterprises, Inc. (NYSE:NUS – Get Rating) will report $578.98 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Nu Skin Enterprises’ earnings. The lowest sales estimate is $576.30 million and the highest is $581.66 million. Nu Skin Enterprises posted sales of $677.03 million during the same quarter last year, which suggests a negative year over year growth rate of 14.5%. The company is expected to announce its next earnings report after the market closes on Monday, January 1st.
According to Zacks, analysts expect that Nu Skin Enterprises will report full year sales of $2.70 billion for the current fiscal year, with estimates ranging from $2.70 billion to $2.71 billion. For the next year, analysts forecast that the company will post sales of $2.77 billion, with estimates ranging from $2.74 billion to $2.80 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that cover Nu Skin Enterprises.
Nu Skin Enterprises (NYSE:NUS – Get Rating) last released its quarterly earnings results on Wednesday, February 16th. The company reported $1.11 EPS for the quarter, beating analysts’ consensus estimates of $0.95 by $0.16. The business had revenue of $673.44 million during the quarter, compared to analyst estimates of $655.93 million. Nu Skin Enterprises had a return on equity of 23.39% and a net margin of 5.46%. Nu Skin Enterprises’s quarterly revenue was down 10.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.40 EPS.
A number of equities analysts recently issued reports on NUS shares. Jefferies Financial Group raised their price objective on shares of Nu Skin Enterprises from $61.00 to $75.00 in a report on Thursday, February 17th. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 price target on the stock in a research report on Tuesday, March 29th. TheStreet downgraded shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a research note on Friday, February 18th. StockNews.com started coverage on shares of Nu Skin Enterprises in a report on Thursday, March 31st. They set a “hold” rating on the stock. Finally, DA Davidson lifted their target price on shares of Nu Skin Enterprises from $47.00 to $50.00 and gave the stock a “neutral” rating in a research note on Thursday, February 17th. Four equities research analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average price target of $61.17.
In other news, Director Andrew D. Lipman sold 1,000 shares of the firm’s stock in a transaction dated Friday, April 22nd. The stock was sold at an average price of $47.72, for a total transaction of $47,720.00. Following the completion of the sale, the director now directly owns 71,214 shares of the company’s stock, valued at approximately $3,398,332.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Ryan S. Napierski sold 25,000 shares of the stock in a transaction dated Friday, February 25th. The shares were sold at an average price of $47.40, for a total value of $1,185,000.00. The disclosure for this sale can be found here. In the last three months, insiders sold 29,000 shares of company stock valued at $1,383,890. Company insiders own 4.00% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in NUS. BlackRock Inc. increased its stake in Nu Skin Enterprises by 0.8% during the 3rd quarter. BlackRock Inc. now owns 5,893,635 shares of the company’s stock worth $238,516,000 after purchasing an additional 46,186 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Nu Skin Enterprises by 8.3% during the 3rd quarter. Wellington Management Group LLP now owns 3,450,392 shares of the company’s stock valued at $139,638,000 after purchasing an additional 264,454 shares during the last quarter. Renaissance Technologies LLC lifted its holdings in Nu Skin Enterprises by 3.4% during the 3rd quarter. Renaissance Technologies LLC now owns 2,770,696 shares of the company’s stock valued at $112,130,000 after purchasing an additional 92,400 shares during the last quarter. Capital World Investors lifted its holdings in Nu Skin Enterprises by 10.0% during the 3rd quarter. Capital World Investors now owns 1,100,000 shares of the company’s stock valued at $44,517,000 after purchasing an additional 100,000 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Nu Skin Enterprises by 1.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 921,772 shares of the company’s stock worth $46,780,000 after buying an additional 9,127 shares in the last quarter. Institutional investors own 80.57% of the company’s stock.
Shares of Nu Skin Enterprises stock opened at $45.33 on Friday. Nu Skin Enterprises has a one year low of $39.40 and a one year high of $62.70. The business’s 50 day simple moving average is $48.34 and its two-hundred day simple moving average is $47.48. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.65 and a quick ratio of 0.89. The stock has a market capitalization of $2.26 billion, a P/E ratio of 15.91 and a beta of 1.25.
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 9th. Shareholders of record on Monday, February 28th were given a $0.385 dividend. The ex-dividend date was Friday, February 25th. This is a positive change from Nu Skin Enterprises’s previous quarterly dividend of $0.38. This represents a $1.54 annualized dividend and a yield of 3.40%. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 54.04%.
Nu Skin Enterprises Company Profile (Get Rating)
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Nu Skin Enterprises and related companies with MarketBeat.com’s FREE daily email newsletter.